Valuation: iCAD Inc

Market Cap 11Cr 9.04Cr 8.44Cr 7.74Cr 15Cr 1.01TCr 15Cr 100.07Cr 39Cr 506.35Cr 40Cr 39Cr 1.68TCr P/E 2023
-9.35x
P/E 2024 -8.59x
Enterprise Value 8.87Cr 7.6Cr 7.09Cr 6.51Cr 12Cr 849.19Cr 12Cr 84Cr 33Cr 425.58Cr 33Cr 33Cr 1.41TCr EV / Sales 2023
1.47x
EV / Sales 2024 1.6x
Free-Float
99.32%
Yield 2023 *
-
Yield 2024 -
Manager TitleAgeSince
Chief Executive Officer 61 10/03/2023
Director of Finance/CFO 54 17/07/2025
Corporate Secretary - 17/07/2025
Change 5-day change 1-year change 3-year change Capi.($)
+2.28%+5.31%+26.83%+17.88% 23TCr
+2.09%+5.90%+2.13%-14.12% 15TCr
-5.84%-6.68%-22.06%+30.96% 13TCr
-5.08%-4.49%-53.45%-1.63% 7.15TCr
-2.65%-2.95%+10.37%+17.30% 5.18TCr
-0.31%+0.86%-17.03%-12.82% 5.18TCr
+0.57%+4.70%+31.22%+31.07% 4.41TCr
-2.68%-2.13%+36.38%+49.89% 3.98TCr
-0.75%+0.37%+0.26%+8.34% 3.35TCr
Average -0.25%+0.46%+1.63%+14.10% 8.98TCr
Weighted average by Cap. +0.26%+1.38%+2.84%+12.18%

Financials

2023 2024
Net sales 1.73Cr 1.48Cr 1.38Cr 1.27Cr 2.39Cr 165.71Cr 2.43Cr 16Cr 6.4Cr 83Cr 6.5Cr 6.36Cr 274.94Cr 1.96Cr 1.68Cr 1.57Cr 1.44Cr 2.7Cr 187.62Cr 2.75Cr 19Cr 7.24Cr 94Cr 7.36Cr 7.2Cr 311.29Cr
Net income -48.47L -41.5L -38.72L -35.53L -66.76L -46Cr -68.08L -4.59Cr -1.79Cr -23Cr -1.82Cr -1.78Cr -77Cr -56.16L -48.08L -44.86L -41.17L -77.35L -54Cr -78.88L -5.32Cr -2.07Cr -27Cr -2.11Cr -2.06Cr -89Cr
Net Debt -2.12Cr -1.82Cr -1.69Cr -1.55Cr -2.92Cr -202.94Cr -2.98Cr -20Cr -7.84Cr -101.7Cr -7.96Cr -7.79Cr -336.71Cr -1.68Cr -1.44Cr -1.35Cr -1.23Cr -2.32Cr -161.17Cr -2.37Cr -16Cr -6.22Cr -81Cr -6.32Cr -6.19Cr -267.41Cr
Logo iCAD Inc
iCAD Inc is a United States‑based company. The Company develops artificial intelligence solutions designed to support healthcare providers in the detection and diagnosis of cancer. The company focuses on providing clinically proven AI technologies that assist medical professionals in identifying cancer earlier, improving diagnostic accuracy, and enhancing workflow efficiency. Its solutions include platforms for cancer detection, breast density assessment, and risk evaluation, enabling clinicians to analyze medical images and support patient care decisions. The company leverages advanced data, clinical evidence, and AI‑driven technologies to deliver tools that integrate into existing healthcare systems and assist in screening and diagnostic processes across global markets.
Employees
-